Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human Microbiota and Immunotherapy in Breast Cancer - A Review of Recent Developments
Marina Vitorino, Susana Baptista de Almeida, Diogo Alpuim Costa, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

The role of gut microbiota in T cell immunity and immune mediated disorders
Ju A Shim, Jeong Ha Ryu, Yuna Jo, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 4, pp. 1178-1191
Open Access | Times Cited: 67
A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
Hitesh Kumar, Neha Gupta, Rupshee Jain, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 271-292
Open Access | Times Cited: 59
The gut microbiota in breast cancer development and treatment: The good, the bad, and the useful!
Deeptashree Nandi, Sheetal Parida, Dipali Sharma
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 38
The human microbiome and cancer: a diagnostic and therapeutic perspective
Shruthi Kandalai, Huapeng Li, Nan Zhang, et al.
Cancer Biology & Therapy (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 38
Role of Gut Microbiota in Breast Cancer and Drug Resistance
V Sathiyapriya, Sheetal Parida, Bhuvana Teja Lingipilli, et al.
Pathogens (2023) Vol. 12, Iss. 3, pp. 468-468
Open Access | Times Cited: 33
The combination of flaxseed lignans and PD-1/ PD-L1 inhibitor inhibits breast cancer growth via modulating gut microbiome and host immunity
Hao Wu, J.F. Liu, Xinghua Zhang, et al.
Drug Resistance Updates (2025) Vol. 80, pp. 101222-101222
Open Access | Times Cited: 1
Breast Cancer Survivors and Healthy Women: Could Gut Microbiota Make a Difference?—“BiotaCancerSurvivors”: A Case-Control Study
T. Caleça, Pedro Ribeiro, Marina Vitorino, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 594-594
Open Access | Times Cited: 15
The Role of Obesity in Breast Cancer Pathogenesis
Ira Glassman, Nghia Le, Aamna Asif, et al.
Cells (2023) Vol. 12, Iss. 16, pp. 2061-2061
Open Access | Times Cited: 13
Local Breast Microbiota: A “New” Player on the Block
Marina Vitorino, Diogo Alpuim Costa, Rodrigo Vicente, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3811-3811
Open Access | Times Cited: 19
Nutrition Intervention and Microbiome Modulation in the Management of Breast Cancer
Yue Jiang, Yuanyuan Li
Nutrients (2024) Vol. 16, Iss. 16, pp. 2644-2644
Open Access | Times Cited: 4
Obesity, dysbiosis and inflammation: interactions that modulate the efficacy of immunotherapy
Ashutosh S. Yende, Dipali Sharma
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Bacterial metabolites: Effects on the development of breast cancer and therapeutic efficacy (Review)
Yan Guo, Wenyan Dong, Dezheng Sun, et al.
Oncology Letters (2025) Vol. 29, Iss. 4, pp. 1-9
Open Access
Predictors of Immunotherapy Response in Triple Negative Breast Cancer
Yiduo Hu, Rachel Yoder, Priyanka Sharma
Current Breast Cancer Reports (2025) Vol. 17, Iss. 1
Closed Access
Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy
Saber Imani, Reyhaneh Farghadani, Ghazaal Roozitalab, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
The human microbiome: redefining cancer pathogenesis and therapy
Yogita K. Adlakha, Ravindresh Chhabra
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Successful management of bilateral orbital metastases from invasive lobular breast cancer with abemaciclib and letrozole: a case report and literature review
Nuno Alves, Ana Filipa Duarte, David Fernandes Ribeiro, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Effects of Functional and Nutraceutical Foods in the Context of the Mediterranean Diet in Patients Diagnosed with Breast Cancer
Giovanna Flore, Andrea Deledda, Mauro Lombardo, et al.
Antioxidants (2023) Vol. 12, Iss. 10, pp. 1845-1845
Open Access | Times Cited: 8
Impact of intestinal dysbiosis on breast cancer metastasis and progression
Jin Zhang, Qiqi Xie, Xingfa Huo, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 14
Exploring the human microbiome – A step forward for precision medicine in breast cancer
Asmita Jotshi, Krishna Kishore Sukla, Mohammed Monzoorul Haque, et al.
Cancer Reports (2023) Vol. 6, Iss. 11
Open Access | Times Cited: 7
Review of immune checkpoint blockade and PD-L1 testing in breast cancer
Adelina Baltan, Simona Costache, Abeer M. Shaaban, et al.
Diagnostic histopathology (2024) Vol. 30, Iss. 2, pp. 110-122
Closed Access | Times Cited: 2
The Influence of Microbiota on Breast Cancer: A Review
Cristian Neagoe, Mihaela Ionică, Octavian Constantin Neagoe, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3468-3468
Open Access | Times Cited: 2
Intra-tumoral microbial community profiling and associated metabolites alterations of TNBC
Yi Wang, Dingding Qu, Yali Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Drinking Water Microbiota, Entero-Mammary Pathways, and Breast Cancer: Focus on Nontuberculous Mycobacteria
Ana Maranha, Susana Alarico, Daniela Nunes‐Costa, et al.
Microorganisms (2024) Vol. 12, Iss. 7, pp. 1425-1425
Open Access | Times Cited: 1
Pharmacomicrobiomics of cell-cycle specific anti-cancer drugs – is it a new perspective for personalized treatment of cancer patients?
Karolina Kaźmierczak-Siedlecka, Nikola Bulman, Paweł Ulasiński, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 3
The tremendous clinical potential of the microbiota in the treatment of breast cancer: the next frontier
Yang Wu, Yue Zhang, Wenwen Zhang, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 13, pp. 12513-12534
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top